Evidence map›Paper›PMID 30124165›Full record

ArticleBMC neurology2018

The clinical prognostic significance of hs-cTnT elevation in patients with acute ischemic stroke.

Lanying He, Jian Wang, Weiwei Dong

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04688970 (Personalized Neurorehabilitative Precision Medicine - From Data to Therapies), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04688970 unknown statusnot on this mapstarted 2020, after this paper: background citation

Personalized Neurorehabilitative Precision Medicine - From Data to Therapies

TypeobservationalSponsorUniversity Hospital TuebingenRan2020 to 2022Enrolled500ConditionsStroke, Acute, Outcome, Improvement, Rehabilitation, Upper Extremity ParesisArmsno intervention
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Insular involvement and atrial fibrillation first detected after ischemic stroke: a systematic review and meta-analysis.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Prevalence of myocardial injury in patients after acute ischaemic stroke according to standard criteria.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Biomarkers Utility: At the Borderline between Cardiology and Neurology.Journal of cardiovascular development and disease · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lanying HeDepartment of Neurology, The Second People's Hospital of Chengdu, Chengdu, 400010, People's Republic of China. 531324679@qq.com.ORCID http://orcid.org/0000-0002-7127-6333
Jian WangDepartment of Neurology, The Second People's Hospital of Chengdu, Chengdu, 400010, People's Republic of China. 383376877@qq.com.
Weiwei DongDepartment of Neurology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China, 400030, People's Republic of China.
Chengdu Second People's Hospital · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

Health and Family Planning Commission of Chengdu 2015009
6 · The paper itself

Abstract

backgroundCardiac autonomic dysfunction caused by ischemic stroke might lead to an adverse outcome. Elevated high sensitivity cardiac troponin (hs-cTnT) is a marker of cardiac disease, it can elevate in acute stroke patients. The aim of the present study was to investigate association between serum hs-cTnT with prognosis among patients with acute ischemic stroke.

methodsFive hundred and sixteen patients (mean age 66.19 ± 10.11) with acute ischemic stroke underwent a comprehensive clinical investigation and serum hs-cTnT activity test. All patients were followed up for 3 months. The prognosis was death or major disability (modified Rankin Scale score ≥ 3) at 3 months after acute ischemic stroke.

results22.87% (118/516) of patients had serum hs-cTnT elevation (≥14 ng/l). Compared with normal hs-TnT group, the incidence of insular stroke (adjusted odds ratio, 2.84; 95% confidence interval, 1.48-4.17; P = 0.001) were more likely in patients with hs-cTnT elevation. In fully adjusted models, there was an association between serum hs-cTnT elevation and death (adjusted odds ratio, 3.14; 95% confidence interval, 1.16-8.49; P = 0.02) and major disability(adjusted odds ratio, 2.07; 95% confidence interval, 1.04-4.51; P = 0.04), and composite outcome(adjusted odds ratio,2.22;95% confidence interval,1.10-4.48; P = 0.03).

conclusionsHigher levels of serum hs-cTnT were independently associated with increased risk of death or major disability after stroke onset, suggesting that serum hs-cTnT may have prognostic value in poor outcomes of ischemic stroke.

Indexed as

Brain IschemiaStrokeAgedBiomarkersCohort StudiesHumansMiddle AgedOdds RatioPrognosisTroponin TBiomarkersTroponin TAcute ischemic strokeHeart damageHs-cTnT,electrocardiographic abnormalityInsular stroke

Identifiers

PMID30124165
PMCPMC6102797
OpenAlexW2888387064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.